The FDA has warned a Texas pharmacy for numerous violations, including compounding unapproved drugs and unsanitary conditions. Source: Drug Industry Daily

The FDA issued a warning to an Oklahoma drug manufacturer after inspectors found significant GMP violations, including a lack of product testing. Source: Drug Industry Daily

Merck and Optum, a division of UnitedHealth Group, have launched a multi-year collaboration exploring value-based payment models for pharmaceuticals. Source: Drug Industry Daily

With federal action on drug prices and cost transparency stalled in Congress, three states have pushed through their own legislation, with one bill becoming law and another awaiting a governor’s…

Less than two weeks on the job and FDA Commissioner Scott Gottlieb is getting pressure from Capitol Hill to change official FDA guidance for compounders. Source: Drug Industry Daily

A Utah supplement company drew a warning from the FDA for failing to comply with GMP requirements. Source: Drug Industry Daily

An FDA advisory committee endorsed Hospira’s biosimilar version of Epogen and Procrit, used to stimulate the production of red blood cells. Source: Drug Industry Daily

FDA Commissioner Scott Gottlieb laid out his early priorities before members of Congress Thursday, and announced that the hiring freeze on the agency had officially been lifted. Source: Drug Industry…

In observance of the Memorial Day holiday, Drug Industry Daily will not be published Monday, May 29. The next issue will be published Tuesday, May 30. Source: Drug Industry Daily

Sen. Claire McCaskill (D-Mo.) asked Mallinckrodt for more details on price increases for Ofirmev, the company’s injectable version of acetaminophen. Source: Drug Industry Daily